Retina Drug Co. Settles Investor Row For $29M
By Katryna Perera ( September 13, 2021, 3:10 PM EDT) -- Investors in Ophthotech Corp. asked a New York federal judge Friday to approve a $29 million cash settlement they had reached with the biopharmaceutical company over claims that it misled shareholders regarding clinical trial phases for a macular degeneration drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.